Rocket, Lab’s

Rocket Lab’s Record Year and the SpaceX Valuation Catalyst

10.12.2025 - 17:33:04

Rocket Lab USA US7731221062

As the year draws to a close, Rocket Lab USA is demonstrating remarkable operational momentum. The aerospace firm has not only surpassed its own previous annual launch record but is now accelerating mission timelines. This operational excellence is being complemented by sector-wide excitement fueled by a potential landmark valuation for its rival, SpaceX. The central question for investors is how much of this future potential is already reflected in the current share price.

Beyond its own achievements, Rocket Lab's equity is experiencing a notable tailwind from industry developments. Recent reports suggesting a potential initial public offering for SpaceX in 2026 or 2027, with a valuation that could reach $1.5 trillion, have captured market attention. As the second-most significant launch provider in the United States, Rocket Lab is viewed by the market as a direct beneficiary of any sector-wide re-rating. The expectation is that valuation multiples applied to SpaceX could positively influence its smaller competitor. Concurrently, Rocket Lab is advancing its strategic ambitions with the development of the Neutron rocket, slated for a 2026 debut, which aims to challenge the Falcon 9's dominance in the medium-lift payload segment.

Accelerated Operations and Execution

The immediate driver for optimism is a schedule adjustment—a rare occurrence in the complex aerospace industry. Rocket Lab has moved forward the launch window for its "Bridging The Swarm" mission. Originally planned for a later date, the Electron rocket is now scheduled to lift off as early as tomorrow, December 11 (New Zealand local time).

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

This mission, conducted for the Korean Advanced Institute of Science and Technology (KAIST), will mark the company's 19th launch in 2025. This figure significantly exceeds the previous year's record of 16 missions. Such launch frequency provides tangible evidence to investors that Rocket Lab has successfully reduced turnaround times between flights while enhancing reliability—a critical factor for profitability in the launch services business. This strong operational performance is further supported by a 48 percent year-over-year revenue growth reported for the third quarter.

Risk Considerations and Near-Term Catalysts

Despite the robust operational narrative, certain risk factors warrant attention. Market data reveals significant insider selling activity over the past six months, including transactions by CEO Peter Beck, with no corresponding insider purchases to offset them. Furthermore, the Relative Strength Index (RSI) indicator, reading above 85, suggests the stock may be experiencing short-term overbought conditions.

For investors, the focus now shifts squarely to near-term execution. A successful mission tomorrow is crucial, as it would pave the way for a rapid follow-on launch. Another Electron rocket is already on the pad for a subsequent mission for the Japan Aerospace Exploration Agency (JAXA), currently scheduled for December 13. Achieving this dense launch cadence before year-end would powerfully reinforce the company's scalability story and operational prowess.

Ad

Rocket Lab USA Stock: Buy or Sell?! New Rocket Lab USA Analysis from December 10 delivers the answer:

The latest Rocket Lab USA figures speak for themselves: Urgent action needed for Rocket Lab USA investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from December 10.

Rocket Lab USA: Buy or sell? Read more here...

@ boerse-global.de